Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
OncoCyte Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OCX
Nasdaq
8731
https://oncocyte.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for OncoCyte Corp
Oncocyte Reports Full Year 2023 Financial Results
- Apr 12th, 2024 10:00 am
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
- Apr 12th, 2024 1:46 am
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
- Apr 11th, 2024 9:30 pm
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
- Apr 9th, 2024 8:05 pm
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
- Jan 16th, 2024 1:00 pm
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
- Dec 6th, 2023 1:00 pm
OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon
- Nov 9th, 2023 1:27 pm
Oncocyte Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 12:00 pm
Oncocyte to Announce Third Quarter 2023 Financial Results
- Nov 3rd, 2023 12:30 pm
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
- Sep 18th, 2023 12:00 pm
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 6th, 2023 12:00 pm
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
- Aug 28th, 2023 12:30 pm
Oncocyte Reports Second Quarter 2023 Financial Results
- Aug 10th, 2023 11:00 am
Oncocyte Regains Compliance With Nasdaq Listing Requirements
- Aug 9th, 2023 12:00 pm
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
- Aug 8th, 2023 12:30 pm
Oncocyte To Announce Second Quarter 2023 Financial Results
- Aug 3rd, 2023 12:00 pm
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
- Jul 25th, 2023 1:08 pm
Oncocyte Announces 1-For-20 Reverse Stock Split
- Jul 24th, 2023 5:35 pm
Oncocyte Begins Manufacturing Transplant Blood Test
- Jun 27th, 2023 12:30 pm
Oncocyte Corporation to Present at the LD Micro Invitational XIII
- Jun 1st, 2023 8:15 pm
Scroll